|

March 2016 Vol. 4 No.3
Other viewing option
Abstract
• Full
text
•Reprint
(PDF) (406 KB)
Search Pubmed for articles by:
Shentova
R
Hadjiiski
P
Other links:
PubMed Citation
Related articles in PubMed
|
|
Merit Research Journal of Medicine and Medical
Sciences (ISSN: 2354-323X) Vol. 4(3) pp.
169-172, March, 2016
Copyright © 2016 Merit Research Journals |
|
Original Research Article
Diagnostic Value of Fecal Calprotectin Point
of Care Testing in the Pediatric Practice |
|
|
Rayna Shentova*1, Tsvetelina Velikova2,
Christo Zhelev1, Emilia Panteleeva1, Penka
Yaneva1 and Petio Hadjiiski1 |
|
|
1Department
of Gastroenterology and Hepatology, University Pediatric
Hospital “Prof. Ivan Mitev”, Sofia, Medical University of Sofia,
16, Acad. Iv. Evst. Geshov Blvd., 1606 Sofia, Bulgaria
2Laboratory of Clinical Laboratory and Clinical
Immunology, UMHAT “St. Iv. Rilski”, Sofia, Medical University of
Sofia 15, Acad. Iv. Evst.Geshov Blvd.,1431 Sofia, Bulgaria
*Corresponding Author’s E-mail: rshentova@yahoo.com
Tel: +359 2 81 54 312
Fax: +359 2 81 54 312
Accepted March 20, 2016 |
|
|
We evaluated 54
children – 24 children with inflammatory bowel disease, 15 with
other non-infectious intestinal diseases and 15 healthy
controls. All of the children provided fresh fecal samples for
measurement of Fecal Calprotectin (FC). FC concentration was
assayed by two methods – quantitative point of care test and
ELISA test. The mean FC levels were significantly increased in
all of the patients with intestinal inflammation. There was a
strong correlation between the results obtained from the point
of care test and the ELISA assay. FC point of care testing is a
useful non-invasive screening tool in the pediatric practice.
Key words: Fecal calprotectin, Intestinal inflammation,
Point of care testing
|
|